Search | MakeMyFriends

Subodh Adke added blog Networking
2026-05-05 12:02:55 -

(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....

0 Comments 0 Shares 106 Views 0 Reviews

Please log in to like, share and comment!
Subodh Adke added blog Other
2026-04-09 07:22:03 -

Global Pharmaceutical Grade Cabazitaxel Market Forecast 2034: Oncology Demand, Growth Drivers, and Competitive Insights
Global Pharmaceutical Grade Cabazitaxel market was valued at USD 312 million in 2025 and is projected to reach USD 440 million by 2034, exhibiting a steady compound annual growth rate (CAGR) of 5.2% during the forecast period. Pharmaceutical Grade Cabazitaxel is a high-purity, semi-synthetic taxane derivative specifically engineered for oncology applications. As a microtubule...

0 Comments 0 Shares 81 Views 0 Reviews

Please log in to like, share and comment!
Workin Dbmr added blog Networking
2026-03-16 06:27:33 -

How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?
Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

0 Comments 0 Shares 710 Views 0 Reviews

Please log in to like, share and comment!
Workin Dbmr added blog Networking
2026-03-16 06:40:11 -

What Breakthrough Drug Delivery Technologies Are Fueling the Peptide-Drug Conjugate Therapeutics Market?
Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...

0 Comments 0 Shares 678 Views 0 Reviews

Please log in to like, share and comment!